Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $174B
1-Year Est. Return 31.94%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+31.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$174B
AUM Growth
+$5.79B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,355
New
Increased
Reduced
Closed

Top Buys

1 +$1B
2 +$867M
3 +$642M
4
MSFT icon
Microsoft
MSFT
+$574M
5
AMZN icon
Amazon
AMZN
+$426M

Top Sells

1 +$64.5M
2 +$37.9M
3 +$21.9M
4
PDD icon
Pinduoduo
PDD
+$18.9M
5
FYBR
Frontier Communications
FYBR
+$18.8M

Sector Composition

1 Technology 33.51%
2 Healthcare 10.85%
3 Consumer Discretionary 10.77%
4 Communication Services 10.52%
5 Industrials 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLX icon
1751
Deluxe
DLX
$1.1B
$2.44M ﹤0.01%
88,500
OBK icon
1752
Origin Bancorp
OBK
$1.47B
$2.43M ﹤0.01%
58,582
INOD icon
1753
Innodata
INOD
$3.84B
$2.43M ﹤0.01%
62,800
MCRI icon
1754
Monarch Casino & Resort
MCRI
$2.15B
$2.42M ﹤0.01%
25,311
+300
PVLA
1755
Palvella Therapeutics
PVLA
$1.55B
$2.42M ﹤0.01%
19,400
+5,200
NPKI
1756
NPK International
NPKI
$1.22B
$2.41M ﹤0.01%
166,600
PWP icon
1757
Perella Weinberg Partners
PWP
$1.2B
$2.4M ﹤0.01%
131,900
+5,600
PRA icon
1758
ProAssurance
PRA
$1.24B
$2.39M ﹤0.01%
96,600
-2,300
LOB icon
1759
Live Oak Bancshares
LOB
$1.76B
$2.39M ﹤0.01%
72,200
JJSF icon
1760
J&J Snack Foods
JJSF
$1.43B
$2.39M ﹤0.01%
30,100
-600
HRMY icon
1761
Harmony Biosciences
HRMY
$1.81B
$2.38M ﹤0.01%
85,100
ICFI icon
1762
ICF International
ICFI
$1.26B
$2.37M ﹤0.01%
36,300
RLAY icon
1763
Relay Therapeutics
RLAY
$3.76B
$2.37M ﹤0.01%
238,000
ACT icon
1764
Enact Holdings
ACT
$5.78B
$2.36M ﹤0.01%
57,800
KW icon
1765
Kennedy-Wilson Holdings
KW
$1.53B
$2.35M ﹤0.01%
217,568
DFIN icon
1766
Donnelley Financial Solutions
DFIN
$993M
$2.35M ﹤0.01%
49,900
-1,700
LILAK icon
1767
Liberty Latin America Class C
LILAK
$1.79B
$2.35M ﹤0.01%
265,917
TWO
1768
Two Harbors Investment
TWO
$1.3B
$2.34M ﹤0.01%
205,288
NN icon
1769
NextNav
NN
$2.69B
$2.34M ﹤0.01%
146,100
SEZL
1770
Sezzle
SEZL
$4.05B
$2.34M ﹤0.01%
36,900
CVI icon
1771
CVR Energy
CVI
$3.58B
$2.34M ﹤0.01%
69,400
NRIX icon
1772
Nurix Therapeutics
NRIX
$1.7B
$2.33M ﹤0.01%
150,000
CMPR icon
1773
Cimpress
CMPR
$2.37B
$2.32M ﹤0.01%
31,800
+500
ROCK icon
1774
Gibraltar Industries
ROCK
$1.12B
$2.32M ﹤0.01%
58,200
PEBO icon
1775
Peoples Bancorp
PEBO
$1.25B
$2.31M ﹤0.01%
70,400